The rates of weight gain after stopping Wegovy vary depending on the individual, and available data suggests that with some individuals, weight gain will come back earlier, and with others, it may come later
Participants receiving semaglutide had a significantly lower decline in eGFR than those in the placebo group, indicating semaglutides potential kidney function protection in people with pre-existing kidney impairment
Drexler Y, Molina J, Elfassy T, et al
Research notes Less GH-selective than ipamorelin useful for comparative pharmacology studies
The temptation at this point is to relax everything and coast, but some structure is still important
The OPs are cytotoxic and can impair cellular homeostasis 41